
Very significant progress has been made since the mid-1970s when dye ligands were first introduced.
Very significant progress has been made since the mid-1970s when dye ligands were first introduced.
Helium Out-Detects Soap and Water
The biotechnology and pharmaceutical industries have some overriding concerns, namely regulatory and compliance issues, insufficient manufacturing capacity, and the economic challenges of producing niche drugs and therapies.
by Gary Schultz, Advion BioSciences
by Charles Lambalot, Millipore Corporation
by Suzanne Mattingly, Scimagix, Inc.
by Mary Ellen Goffredo, NuGenesis Technologies Corporation Weighing the Options
by Jane Turton, Central Public Health Laboratory and Zain Moola This case study shows that storing an ion-exchange chromatography gel in dilute alkalai, followed by removal of the solubized material, enhances gel cleaning. More material is removed from the gel during column recycling, and carry over of material from one cycle to the next is substantially reduced.
By Jim Erickson, Blue Mountain Quality Resources, Inc., pp. 63-64. In the fast-paced biopharmaceutical manufacturing environment, "speed to market" is the hallmark catch phrase. Many companies are focusing only on the processes that add the most value and are outsourcing the rest. This focus on core competencies has some biotech companies reevaluating their calibration practices. Many are contracting more of that workload, from both laboratory and production facilities, to calibration service laboratories.